Archive - Behind BioML

The state of research on virtual cell modeling

Measuring where we are on the emerging grand challenge

Jul 9 •

January 2025

Eroom's Law in the Age of AI

Quantity vs. quality in discovery research

Jan 16 •

December 2024

A semantic map of NeurIPS 24' Workshop on AI for New Drug Modalities

Interactively explore related research papers at the AIDrugX Workshop

Dec 12, 2024 •

October 2024

Bio x ML hackathon: our 3rd-place winning project

Generative DNA design for plasmid vector engineering

Oct 22, 2024 •

Variational synthesis: a new generative design paradigm for biology

Bridging the gap between digital design and physical manufacturing

Oct 3, 2024 •

August 2024

Scaling biology: genomics

Genomics data & measurement technology growth trends

Aug 26, 2024 •

June 2024

Picks & shovels of the AI bioeconomy

Design-test as a service

Jun 25, 2024 •

May 2024

An emerging business model in drug development

Software-first, generative biodesign

May 9, 2024 •

April 2024

Scaling biology: transcriptomics

scRNA-seq data scaling trends

Apr 8, 2024 •

March 2024

Computation through the lens of biology

The bioML stack: sequence, structure & systems

Mar 13, 2024 •

February 2024

ML for target identification

Four frameworks for modeling the problem

Feb 26, 2024 •

The evolution of ML in early-stage drug development

Feb 16, 2024 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts